THE IMPORTANCE OF TOXOPLASMA GONDII INFECTION IN DISEASES PRESENTING WITH HEADACHES. HEADACHES AND ASEPTIC MENINGITIS MAY BE MANIFESTATIONS OF THE JARISCH-HERXHEIMER REACTION

REFERENCES

• Adenis, J. P., Lebraud, P., Ravon, R., Robin, A., & Decaie, A. (1982). Papilledema and choroidal folds in benign intracranial hypertension. Bulletin de la Société d'Ophthalmologie de Paris, 82, 1223–1225.
   Google Scholar
• Agid, R., & Farb, R. I. (2006). Neuroimaging in the diagnosis of idiopathic intracranial hypertension. Minerva Medica, 97, 365–370.
   PubMedGoogle Scholar
• Agostoni, E., & Rigamoni, A. (2007). Migraine and cerebrovascular disease. Neurological Sciences, 28, S156–S160.
   PubMedGoogle Scholar
• Aliberti, J. (2005). Host persistence: Exploitation of anti-inflammatory pathways by Toxoplasma gondii. Nature Reviews of Immunology, 5, 162–170.
   PubMed Web of Science ®Google Scholar
• Ambrosetto, G., Antonioni, L., & Tassinari, C. A. (1992). Occipital lobe seizures related to clinically asymptomatic celiac disease in childhood. Epilepsia, 33, 476–481.
   PubMed Web of Science ®Google Scholar
• Appenzeller, S., Kobayashi, E., Costallat, L. T. L., De Araujo Zanardi, V., Neto, J. M. R., Pereira Damasceno, B., (2000). Magnetic resonance imaging in the evaluation of patients with aseptic meningoencephalitis aznd connective tissue disorders. Arquivos de neuro-psiquiatria, 58, 45–51.
   PubMedGoogle Scholar
• Aroichane, M., Miller, N. R., & Eggenberger, E. R. (1993). Glioblastoma multiforme masquerading as pseudotumor cerebri: Case report. Journal of Clinical Neuroophthalmology, 13, 105–112.
   PubMedGoogle Scholar
• Arrizabalaga, G., & Boothroyd, J. C. (2004). Role of calcium during Toxoplasma gondii invasion and egress. International Journal of Parasitology, 34, 361–368.
   PubMedGoogle Scholar
• Arroyo, H. A., De Rosa, S., Ruggieri, V., de Davila, M. T., & Fejerman, N. (2002). Epilepsy, occipital calcifications, and oligosymptomatic celiac disease in childhood. Journal of Child Neurology, 17, 800–806.
   PubMedGoogle Scholar
• Bakkaloglu, S. A., Ekim, M., Tumer, N., Deda, G., Erden, I., & Erdem, T. (2000). Cerebral vasculitis in Henoch-Schönlein purpura. Nephrology Dialysis and Transplantation, 15, 246–248.
   PubMedGoogle Scholar
• Ball, A. K., & Clarke, C. E. (2006). Idiopathic intracranial hypertension. Lancet Neurology, 5, 433–442.
   PubMed Web of Science ®Google Scholar
• Barkana, Y., Levin, N., Goldhammer, Y., & Steiner, I. (2004). Chronic intracranial hypertension with unexplained cerebrospinal fluid pleocytosis. Journal of Neuroophthalmology, 24, 106–108.
   PubMedGoogle Scholar
• Bassan, H., Berkner, L., Stolovitch, C., & Kesler, A. (2008). Asymptomatic idiopathic intracranial hypertension in children. Acta Neurologica Scandinavica, 118, 251–255.
   PubMed Web of Science ®Google Scholar
• Bateman, G. A. (2002). Vascular hydraulics associated with idiopathic and secondary intracranial hypertension. AJNR American Journal of Neuroradiology, 23, 1180–1186.
   PubMedGoogle Scholar
• Bates, G. W., Whitworth, N. S., Parker, J. L., & Johnson, M. P. (1982). Elevated cerebrospinal fluid prolactin concentrations in women with pseudotumor cerebri. South Medical Journal, 75, 807–808.
   PubMedGoogle Scholar
• Beaman, M. H., Hunter, C. A., & Remington, J. S. (1994). Enhancement of intracellular replication of Toxoplasma gondii by IL-6: Interactions with IFN-gamma and TNF-alpha. Journal of Immunology, 153, 4583–4587.
   PubMed Web of Science ®Google Scholar
• Belman, A. L., Leicher, C. R., Moshe, S. L., & Mezey, A. P. (1985). Neurologic manifestations of Schönlein-Henoch purpura: Report of three cases and review of literature. Pediatrics, 75, 687–692.
   PubMed Web of Science ®Google Scholar
• Benedetto, N., Folgore, A., Galdiero, M., Meli, R., & Carlo, R. (1995). Effect of prolactin, rIFN-gamma or rTNF-alpha in murine toxoplasmosis. Pathologie Biologie, 43, 395–400.
   PubMedGoogle Scholar
• Benedetto, N., Folgore, A., Gorga, F., Fiamore, E., Rao, M., & Galdiero, F. (2000). Interactions between cytokines and growth hormone for resistance to experimental intracellular T. gondii infection. New Microbiologica, 23, 167–183.
   PubMedGoogle Scholar
• Benedetto, N., Folgore, A., Romano Carratelli, C., & Galdiero, F. (2001). Effects of cytokines and prolactin on the replication of Toxoplasma gondii in murine microglia. European Cytokine Network, 12, 348–358.
   PubMedGoogle Scholar
• Bhopale, G. M. (2003). Pathogenesis of toxoplasmosis. Comparative Immunology Microbiology and Infectious Diseases, 26, 213–222.
   PubMedGoogle Scholar
• Bicakci, K., Bicakci, S., & Aksungur, E. (2006). Perfusion and diffusion magnetic resonance imaging in idiopathic intracranial hypertension. Acta Neurologica Scandinavica, 114, 193–197.
   PubMed Web of Science ®Google Scholar
• Bokura, H., Kobayashi, S., Yamaguchi, S., Iijima, K., Nagai, A., Toyoda, G., (2006). Silent brain infarction and subcortical white matter lesions increase the risk of stroke and mortality: A prospective cohort study. Journal of Stroke and Cerebrovascular Diseases, 15, 57–63.
   PubMedGoogle Scholar
• Bou, G., Figueroa, M. S., Marti-Belda, P., Navas, E., & Guerrero, A. (1999). Value of PCR for detection of Toxoplasma gondii in aqueous humor and blood samples from immunocompetent patients with ocular toxoplasmosis. Journal of Clinical Microbiology, 37, 3465–3468.
   PubMed Web of Science ®Google Scholar
• Bozzola, M., De Benedetti, F., De Amici, M., Jouret, B., Travaglino, P., & Pagani, S. (2003). Stimulating effect of growth hormone on cytokine release in children. European Journal of Endocrinology, 149, 397–401.
   PubMedGoogle Scholar
• Bushara, K. O. (2005). Neurologic presentation of celiac disease. Gastroenterology, 128, S92–S97.
   PubMed Web of Science ®Google Scholar
• Butcher, B. A., Kim, L., Johnson, P. F., & Denkers, E. Y. (2001). Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NF-κB. Journal of Immunology, 167, 2193–2201.
   PubMedGoogle Scholar
• Carruthers, V. B., & Sibley, L. D. (1999). Mobilization of intracellular calcium stimulates microneme discharge in Toxoplasma gondii. Molecular Microbiology 31, 421–428.
   PubMedGoogle Scholar
• Casciotti, L., Ely, K. H., Williams, M. E., & Khan, I. A. (2002). CD8+-T-cell immmunity against Toxoplasma gondii can be induced but not maintained in mice lacking conventional CD4+ T cells. Infection and Immunity, 70, 434–443.
   PubMedGoogle Scholar
• Castillo Salinas, F., Sole Mir, E., Ferrer Comalat, A., & Morales Sanchez, M. (1990). Benign intracranial hypertension caused by DTP and polio immunization. Anales Espanoles de Pediatria, 32, 466–467.
   PubMedGoogle Scholar
• Chang, L., Cornford, M. E., Chiang, F. L., Ernst, T. M., Sun, N. C. J., & Miller, B. L. (1995). Radiologic-pathologic correlation: Cerebral toxoplasmosis and lymphoma in AIDS. American Journal of Neuroradiology, 16, 1653–1663.
   PubMedGoogle Scholar
• Chansoria, M., Agrawal, A., Ganghoriya, P., & Raghu Raman, B. (2005). Pseudotumor cerebri with transient oculomotor palsy. Indian Journal of Pediatrics, 72, 1047–1048.
   PubMedGoogle Scholar
• Chao, C. C., Hu, S., Gekker, G., Novick, W. J., Jr, Remington, J. S., & Peterson, P. K. (1993). Effects of cytokines on multiplication of Toxoplasma gondii in microglial cells. Journal of Immunology, 150, 3404–3410.
   PubMedGoogle Scholar
• Chapman, A., Keane, P. E., Meldrum, B. S., Simiand, J., & Vernieres, J. C. (1982). Mechanisms of anticonvulsant action of valproate. Progress in Neurobiology, 19, 315–359.
   PubMed Web of Science ®Google Scholar
• Chaudhari, A. B., Singh, A., Jindal, S., & Poon, T. P. (1989). Haemorrhage in cerebral toxoplasmosis: A report on a patient with the acquired immunodeficiency syndrome. South African Medical Journal, 76, 272–274.
   PubMedGoogle Scholar
• Chen, C. L., Chiou, Y. H., Wu, C. Y., Lai, P. H., & Chung, H. M. (2000). Cerebral vasculitis in Henoch-Schönlein purpura: A case report with sequential magnetic resonance imaging changes and treated with plasmapheresis alone. Pediatric Nephrology, 15, 276–278.
   PubMedGoogle Scholar
• Coskun, O., Ücler, S., Cavdar, L., & Inan, L. E. (2007). Effect of valproic acid on withdrawal therapy in patients with overuse of chronic daily headache medications. Journal of Clinical Neuroscience, 14, 334–339.
   PubMedGoogle Scholar
• Curry, W. T., Jr., Butler, W. E., & Barker, F. G., II. (2005). Rapidly increasing incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988–2002. Neurosurgery, 57, 97–108.
   PubMed Web of Science ®Google Scholar
• Dandy, W. E. (1937). Intracranial pressure without brain tumor: Diagnosis and treatment. Annals of Surgery, 106, 492–513.
   PubMedGoogle Scholar
• Debroucker, T., Benhamida, C., Bedos, J. P., Michon, C., & Matheron, S. (1991). Hemorrhagic forms of cerebral toxoplasmosis in human immunodeficiency virus infection. 4 cases. Annales de Medicine Interne (Paris), 142,305–307.
   PubMedGoogle Scholar
• Desguerre, I., & Ponsot, G. (1993). Acquired cerebral toxoplasmosis in a non-immunosuppressed child. Archives Française de Pediatrie, 50, 339–342.
   PubMedGoogle Scholar
• De Simone, R., Marano, E., Fiorillo, C., Briganti, F., Di Salle, F., Volpe, A., (2005). Sudden re-opening of collapsed transverse sinuses and longstanding clinical remission after a single lumbar puncture is a case of idiopathic intracranial hypertension. Pathogenetic implications. Neurological Sciences, 25,342–344.
   PubMed Web of Science ®Google Scholar
• Diaz, R. M., Gonzalez-Rabelino, G., & Delfino, A. (2005). Epilepsy, cerebral calcifications and coeliac disease: The importance of early diagnosis. Revue de Neurologigue, 40, 417–420.
   PubMedGoogle Scholar
• Diehl, S., & Rincon, M. (2002). The two faces of IL-6 on Th1/Th2 differentiation. Molecular Immunology, 39, 531–536.
   PubMed Web of Science ®Google Scholar
• Dietrich, U., Maschke, M., Dorfler, A., Prumbaum, M., & Forsting, M. (2000). MRI of intracranial toxoplasmosis after bone marrow transplantation. Neuroradiology, 42, 14–18.
   PubMed Web of Science ®Google Scholar
• Digre, K. B. (1999). Idiopathic intracranial hypertension. Current Treatment Options in Neurology, 1, 74–81.
   PubMedGoogle Scholar
• Distelmaier, F., Mayatepek, E., & Tibussek, D. (2008). Probable idiopathic intracranial hypertension in pre-pubertal children. Archives of Diseases in Childhood, 93, 356–357.
   PubMedGoogle Scholar
• Distelmaier, F., Tibussek, D., Schneider, D. T., & Mayatepek, E. (2007). Seasonal variation and atypical presentation of idiopathic intracranial hypertension in pre-pubertal children. Cephalagia, 27, 1261–1264.
   PubMedGoogle Scholar
• Drigo, P., Laverda, A. M., Casara, G. L., Battistella, P. A., & Zampieri, P. (1983). Benign intracranial hypertension in infants. La Pediatria Medica e Chirurgica, 5, 583–585.
   PubMedGoogle Scholar
• Drozdowski, W., & Pogorzelski, R. (2005). Features of intracranial hypertension as a manifestation of cauda equina tumor. Neurologia i Neurochirurgia Polska, 38, 227–230.
   Google Scholar
• Dubey, J. P. (1998). Advances in the life cycle of Toxoplasma gondii. International Journal of Parasitology, 28, 1019–1024.
   PubMed Web of Science ®Google Scholar
• Dubey, J. P., & Beattie, C. P. (1988). Toxoplasmosis in Animals and Man. Boca Raton, FL: CRC Press, 1–220.
   Google Scholar
• Duffy, T. N., Genta, M., Moll, S., Martin, P. Y., & Gabay, C. (2006). Henoch-Schönlein purpura following etanercept treatment of rheumatoid arthritis. Clinical and Experimental Rheumatology, 24(2 Suppl 41), S106.
   Google Scholar
• Duggan, P. J., Maalouf, E. F., Watts, T. L., Sullivan, M. H., Counsell, S. J., Allsop, J., (2001). Intrauterine T-cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions. Lancet, 358, 1699–1700.
   PubMed Web of Science ®Google Scholar
• Dyet, L. E., Kennea, N., Counsell, S. J., Maalouf, E. F., Ajayi-Obe, M., Duggan, P. J., (2006). Natural history of brain lesions in extremely preterm infants studied with serial magnetic resonance imaging from birth and neurodevelopment assessment. Pediatrics, 118, 536–548.
   PubMed Web of Science ®Google Scholar
• Dzitko, K., Malicki, S., & Komorowski, J. (2008). Effect of hyperprolactinaemia on Toxoplasma gondii prevalence in humans. Parasitology Research, 102, 723–729.
   PubMedGoogle Scholar
• Ertekin, V., Selimoglu, M. A., Turkan, Y., & Akcay, F. (2005). Serum nitric oxide levels in children with celiac disease. Journal of Clinical Gastroenterology, 39, 782–785.
   PubMedGoogle Scholar
• Ferrari, M. D. (1998). Migraine. Lancet, 351, 1043–1051.
   PubMed Web of Science ®Google Scholar
• Flegr, J., Preiss, M., Klose, J., Havliček, J., Vitáková, M., & Kodym, P. (2003). Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii. Dopamine, a missing link between schizophrenia and toxoplasmosis. Biological Psychology, 63, 253–268.
   PubMed Web of Science ®Google Scholar
• Fois, A., Vascotto, M., Di Bartolo, R. M., & Di Marco, V. (1994). Celiac disease and epilepsy in pediatric patients. Child's Nervous System, 10, 450–454.
   PubMedGoogle Scholar
• Foley, J. (1955). Benign forms of intracranial hypertension—Toxic and otitic hydrocephalus. Brain, 78, 1–41.
   PubMed Web of Science ®Google Scholar
• Freedman, S. B., Reed, J., Burwen, D. R., Wise, R. P., Weiss, A., & Ball, R. (2005). Transient bulging fontanelle after vaccination: Case report and review of the vaccine adverse event reporting system. Journal of Pediatrics, 147,640–644.
   PubMedGoogle Scholar
• Friedman, D. I. (2004). Pseudotumor cerebri. Neurology Clinics of North America, 22, 99–131.
   PubMed Web of Science ®Google Scholar
• Friedman, D. I., & Jacobson, D. M. (2002). Diagnostic criteria for idiopathic intracranial hypertension. Neurology, 59, 1492–1495.
   PubMed Web of Science ®Google Scholar
• Fryden, A. (1977). B and T lymphocytes in blood and cerebrospinal fluid in acute aseptic meningitis. Scandinavian Journal of Immunology, 6, 1282–1288.
   PubMedGoogle Scholar
• Fryden, A., Kam-Hansen, S., Maller, R., & Link, H. (1980). Active and total T cells in blood and cerebrospinal fluid during the course of aseptic meningitis. Acta Neurologica Scandinavica, 61, 306–312.
   PubMed Web of Science ®Google Scholar
• Fujigaki, S., Saito, K., Takemura, M., Maekawa, N., Yamada, Y., Wada H., (2002). L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma-interferon-gene-deficient mice: Cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase. Infection and Immunity, 70, 779–786.
   PubMed Web of Science ®Google Scholar
• Gabrielli, M., Cremonini, F., Fiore, G., Addolorato, G., Padalino, C., Candelli, M., (2003). Association between migraine and celiac disease: Results from a preliminary case-control and therapeutic study. American Journal of Gastroenterology, 98, 625–629.
   PubMed Web of Science ®Google Scholar
• Gazzinelli, R. T., Eltoum, I., Wynn, T. A., & Sher, A. (1993). Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. Journal of Immunology, 151, 3672–3681.
   PubMed Web of Science ®Google Scholar
• Ghose, K., & Niven, B. (1998). Prophylactic sodium valproate therapy in patients with drug-resistant migraine. Methods and Findings in Experimental and Clinical Pharmacology, 20, 353–359.
   PubMedGoogle Scholar
• Gideon, P., Sorensen, P. S., Thomsen, C., Ståhlberg, F., Gjerris, F., & Henriksen, O. (1995). Increased brain water self-diffusion in patients with idiopathic intracranial hypertension. American Journal of Neuroradiology, 16, 381–387.
   PubMedGoogle Scholar
• Gobbi, G. (2005). Coeliac disease, epilepsy and cerebral calcifications. Brain and Development, 27, 189–200.
   PubMed Web of Science ®Google Scholar
• Good, C. D., Wade, A. M., Hayward, R. D., Phipps, K. P., Michalski, A. J., Harkness, W. F., (2001). Surveillance neuroimaging in childhood intracranial ependymoma: How effective, how often, and for how long? Journal of Neurosurgery, 94, 27–32.
   PubMedGoogle Scholar
• Goodwin, D. G., Strobl, J., Mitchell, S. M., Zajac, A. M., & Lindasy, D. S. (2008). Evaluation of the mood-stabilizing agent valproic acid as a preventative for toxoplasmosis in mice and activity against tissue cysts in mice. Journal of Parasitology, 94, 555–557.
   PubMedGoogle Scholar
• Griffin, G. E. (1998). Cytokines involved in human septic shock—The model of the Jarisch-Herxheimer reaction. Journal of Antimicrobial Chemotherapy, 41(Suppl A), 25–29.
   PubMedGoogle Scholar
• Gross, U., Kempf, M. C., Seeber, F., Luder, C. G., Lugert, R., & Bohne W. (1997). Reactivation of chronic toxoplasmosis: Is there a link to strain-specific differences in the parasite? Behring Institute Mitteilungen, 99, 97–106.
   Google Scholar
• Gross, T. P., Milstien, J. B., & Kuritsky, J. N. (1989). Bulging fontanelle after immunization with diphtheria-tetanus-pertussis vaccine and diphtheria-tetanus vaccine. Journal of Pediatrics, 114, 423–425.
   PubMedGoogle Scholar
• Guk, S. M., Kook, J., Jeon, Y. H., Choi, J. H., Han, E. T., Shin, E. H., (2005). Suppressed cytokine and immunoglobulin secretions by murine splenic lymphocytes infected in vitro with Toxoplasma gondii tachyzoites. Journal of Parasitology, 91, 467–470.
   PubMed Web of Science ®Google Scholar
• Ha, T. S., & Cha, S. H. (1996). Cerebral vasculitis in Henoch-Schönlein purpura: A case report with sequential magnetic resonance imaging. Pediatric Nephrology, 10, 634–636.
   PubMedGoogle Scholar
• Hansen, R. A., Gartlehner, G., Powell, G. E., & Sandler, R. S. (2007). Serious adverse events with infliximab: Analysis of spontaneously reported adverse events. Clinical Gastroenterology and Hepatology, 5, 729–735.
   PubMed Web of Science ®Google Scholar
• Hansson, T., Dannaeus, A., & Klareskog, L. (1999). Cytokine-producing cells in peripheral blood of children with coeliac disease secrete cytokines with a type 1 profile. Clinical and Experimental Immunology, 116, 246–250.
   PubMedGoogle Scholar
• Harrison, P. B. (1998). Neurological imaging: CT and MRI. In J. W. Reeders and J. R. Mathieson ( eds.), AIDS Imaging: A Practical Clinical Approach. London: Saunders, 98–120.
   Google Scholar
• Headache Classification Subcommittee of the International Headache Society (2004). The International Classification of Headache Disorders, 2nd ed. Cephalalgia, 24(Suppl. 1), 1–160.
   Google Scholar
• Horrobin, D. F. (1973). Prevention of migraine by reducing prolactin levels. Lancet, 1, 777.
   PubMed Web of Science ®Google Scholar
• Hu, W. T., Murray, J. A., Greenaway, M. C., Parisi, J. E., & Josephs, K. A. (2006). Cognitive impairment and celiac disease. Archives of Neurology, 63, 1440–1446.
   PubMedGoogle Scholar
• Hurst, D. L. (1987). Expanded therapeutic range of valproate. Pediatric Neurology, 3, 342–344.
   PubMedGoogle Scholar
• Ichiyama, T., Okada, K., Lipton, J. M., Matsubara, T., Hayashi, T., & Furukawa, S. (2000). Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB. Brain Research, 28, 246–251.
   Google Scholar
• Iqbal, H., & Evans, A. (2005). Dapsone therapy for Henoch-Schönlein purpura: A case series. Archives Diseases in Childhood, 90, 985–986.
   PubMedGoogle Scholar
• Jacobson, D. M. (1995). Intracranial hypertension and the syndrome of acquired hyperopia with choroidal folds. Journal of Neuroophthalmology, 15,178–185.
   PubMed Web of Science ®Google Scholar
• Jafoui, M., Asbai, K., Louhab, N., & Kissani, N. (2005). Partial epilepsy revealing cerebral toxoplasmosis in an immunocompetent patient (Abstract 0102). Journal of Neurological Science, 238, S126.
   Google Scholar
• James, M. J. (1989). Ischemia, hydrocephalus, atrophy, and neurodegenerative disorders: MRI experience at high field strength (1.5 T). In P.J. Stephen ( ed.), Craniospinal Resonance Imaging. Philadelphia: Saunders Co., 351–398.
   Google Scholar
• Johnson, L. N., Krohel, G. B., Madsen, R. W., & March, G. A., Jr. (1998). The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology, 105, 2313–2317.
   PubMed Web of Science ®Google Scholar
• Jones-Brando, L., Fuller Torrey, E., & Yolken, R. (2003). Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophrenia Research, 62, 237–244.
   PubMed Web of Science ®Google Scholar
• Kang, K. M., Choi, I. U., Shin, D. W., & Lee, Y. H. (2006). Cytokine and antibody responses of reactivated murine toxoplasmosis upon administration of dexamethasone. Korean Journal of Parasitology, 44, 209–219.
   PubMedGoogle Scholar
• Karabiber, H., Yakinci, C., Durmaz, Y., Temel, I., & Mehmet, N. (2004). Serum nitrite and nitrate levels in epileptic children using valproic acid or carbamazepine. Brain Development, 26, 15–18.
   PubMed Web of Science ®Google Scholar
• Kastenbauer, S., Pfister, H. W., & Wick, M. (2003). No evidence of type 1 or type 3 hypersensitivity mechanism in amoxicillin/clavulanic acid induced aseptic meningitis. Journal of Neurology Neurosurgery and Psychiatry, 74,690–691.
   PubMed Web of Science ®Google Scholar
• Kawaguchi, R., Ozawa-Kondo, M., Ohta-Misaki, I., Suzuki-Karasaki, M., Hayakawa, S., Yamamoto, T., (2005). Prolactin (PRL) up-regulates indoleamine 2,3-dioxygenase (IDO) expression in CD14+ cells. Nihon Rinsho Meneki Gakkai Kaishi, 28, 407–412.
   PubMedGoogle Scholar
• Kawai, Y., & Arinze, I. J. (2006). Valproic acid-induced gene expression through production of reactive oxygen species. Cancer Research, 66, 63–69.
   Google Scholar
• Khan, E. A., & Correa, A. G. (1997). Toxoplasmosis of the central nervous system in non-human immunodeficiencyvirus-infected children: Case report and review of the literature. Pediatric Infectious Disease Journal, 16, 611–618.
   PubMedGoogle Scholar
• Kieslich, M., Errazuriz, G., Posselt, H. G., Moeller-Hartmann, W., Zanella, F., & Boehles, H. (2001). Brain white-matter lesions in celiac disease: A prospective study of 75 diet-treated patients. Pediatrics, 108, e21.
   Web of Science ®Google Scholar
• Kim, S. K., & Boothroyd, J. C. (2005). Stage-specific expression of surface antigens by Toxoplasma gondii as a mechanism to facilitate parasite persistence. Journal of Immunology, 174, 8038–8048.
   PubMedGoogle Scholar
• Krause, I., Kornreich, L., Waldman, D., & Garty, B. Z. (1997). MRI meningeal enhancement with intracranial hypotension caused by lumbar puncture. Pediatric Neurology, 16, 163–165.
   PubMedGoogle Scholar
• Kruit, M. C., Launer, L. J., Ferrari, M. D., & van Buchem, M. A. (2006). Brain stem and cerebellar hyperintense lesions in migraine. Stroke, 37, 1109–1112.
   PubMed Web of Science ®Google Scholar
• Kruit, M. C., Launer, L. J., van Buchem, M. A., Terwindt, G. M., & Ferrari, M. D. (2005). MRI findings in migraine. Revue de Neurologie (Paris), 161, 661–665.
   PubMed Web of Science ®Google Scholar
• Kur-Zalewska, J., Sworowska-Knap, J., & Tłustochowicz, W. (2008). Neurological disorders with demyelinating brain white matter lesions in a patient with rheumatoid arthritis treated with etanercept. Polskie Archiwum Medycyny Wewnętrznej, 118, 234–237.
   PubMedGoogle Scholar
• Labauge, R., Gros, C., Pages, M., Benezech, J., & Salvaing, P. (1984). Intracranial hypertension and ependymoma of the end of the spinal cord. Revue de Neurologie (Paris), 140, 212–216.
   PubMedGoogle Scholar
• Lahat, N., Shapiro, S., Karban, A., Gerstein, R., Kinarty, A., & Lerner, A. (1999). Cytokine profile in coeliac disease. Scandinavian Journal of Immunology, 49, 441–446.
   PubMed Web of Science ®Google Scholar
• Lassoued, S., Zabraniecki, L., Marin, F., & Billey, T. (2007). Toxoplasmic chorioretinitis and antitumor necrosis factor treatment in rheumatoid arthritis. Seminars in Arthritis and Rheumatology, 36, 262–263.
   PubMed Web of Science ®Google Scholar
• Lavinsky, J., Lavinsky, D., Lavinsky, F., & Frutuoso, A. (2007). Acquired choroidal folds: A sign of idiopathic intracranial hypertension. Graefes Archive for Clinical and Experimental Ophthalmology, 245, 883–888.
   PubMed Web of Science ®Google Scholar
• Lescop, J., Brinquin, L., Schill, H., Soulié, D., Sarrazin, J. L., & Cordoliani, Y. S. (1995). Diffuse toxoplasmic encephalitis in a non-immunosuppressed patients. Journal of Radiology, 76, 21–24.
   PubMedGoogle Scholar
• Loeb, J. A., Sohrab, S. A., Huq, M., & Fuerst, D. R. (2006). Brain calcifications induce neurological dysfunction that can be reversed by a bone drug. Journal of Neurological Science, 243, 77–81.
   PubMedGoogle Scholar
• Lovett, J. L., & Sibley, D. (2003). Intracellular calcium stores in Toxoplasma gondii govern invasion of host cells. Journal of Cell Sciences, 116, 3009–3016.
   PubMedGoogle Scholar
• Luft, B. J., & Remington, J. S. (1992). Toxoplasmic encephalitis in AIDS. Clinical Infectious Diseases, 15, 211–222.
   PubMed Web of Science ®Google Scholar
• Malcolm, P. N., Howlett, D. C., Saks, A., Smith, N. A., Banerjee, A. K., Bingham, J. S., (1999). MRI of the brain in HIV-positive patients: What is the value of routine intravenous contrast medium? Neuroradiology, 41, 687–695.
   PubMedGoogle Scholar
• Malozowski, S., Tanner, L. A., Wysowski, D. K., Fleming, G. A., & Stadel, B. V. (1995). Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone. Journal of Pediatrics, 126, 996–999.
   PubMed Web of Science ®Google Scholar
• Mann, N. P., McLellan, N. J., & Cartlidge, P. H. (1988). Transient intracranial hypertension of infancy. Archives of Diseases in Childhood, 63, 966–968.
   PubMedGoogle Scholar
• Margalit, E., Sung, J. U., Da, D. V., Yohay, K., & Nguyen, Q. D. (2005). Panuveitis in association with pseudotumor cerebri. Journal of Child Neurology, 20, 234–236.
   PubMedGoogle Scholar
• Mathew, M. J., & Chandy, M. J. (1999). Central nervous system toxoplasmosis in acquired immunodeficiency syndrome. Neurology India, 47, 182–187.
   PubMedGoogle Scholar
• Matthews, Y. Y. (2008). Drugs used in childhood idiopathic or benign intracranial hypertension. Archives of Disease in Childhood Education and Practice, 93, 19–25.
   Google Scholar
• McLeod, R., & Remington, J. S. (1992). Toxoplasmosis. In R. E. Behrman, R. M. Kliegman, W. E. Nelson, and V. C. Vaughan, ( eds.), Nelson Textbook of Pediatrics, 14th ed., Philadelphia, PA: WB Saunders Co., 883–892.
   Google Scholar
• Minamishima, I., Ohga, S., Ishii, E., Miyazaki, C., Hamada, K., Akazawa, K., (1991). Aseptic meningitis in children: Correlation between fever and interferon-gamma level. European Journal of Pediatrics, 150, 722–725.
   PubMedGoogle Scholar
• Misra, A. K., Biswas, A., Das, S. K., Gharai, P. K., & Roy, T. (2004). Henoch-Schönlein purpura with intracerebral haemorrhage. Journal of Association of Physicians in India, 52, 833–834.
   PubMedGoogle Scholar
• Montoya, J. G., & Liesenfeld, O. (2004). Toxoplasmosis. Lancet, 12, 1965–1976.
   Google Scholar
• Moris, G., & Garcia-Monco, J. C. (1999). The challenge of drug-induced aseptic meningitis. Archives of Internal Medicine, 159, 1185–1194.
   PubMed Web of Science ®Google Scholar
• Moser, F. G., Hilal, S. K., Abrams, G., Bello, J. A., Schipper, H., & Silver, A. J. (1988). MR imaging of pseudotumor cerebri. AJR American Journal of Roentgenology, 150, 903–909.
   PubMedGoogle Scholar
• Mueller-Mang, C., Mang, T. G., Kalhs, P., & Thurnher, M. M. (2006). Imaging characteristics of toxoplasmosis encephalitis after bone marrow transplantation: Report of two cases and review of the literature. Neuroradiology, 48, 84–89.
   PubMed Web of Science ®Google Scholar
• Murialdo, G., & Polleri, A. (1987). Prolactin and migraine. Headache, 27, 278–279.
   PubMedGoogle Scholar
• Oberdorfer, C., Adams, O., MacKenzie, C. R., De Groot, C. J., & Daubener, W. (2003). Role of IDO activation in anti-microbial defense in human native astrocytes. Advances in Experimental Medicine and Biology, 527, 15–26.
   PubMedGoogle Scholar
• Østergaard, J. R., & Storm, K. (1991). Neurologic manifestations of Schönlein-Henoch purpura. Acta Paediatrica Scandinavica, 80, 339–342.
   PubMedGoogle Scholar
• Parness-Yossifon, R., Margalit, D., Pollack, A., & Leiba, H. (2008). Behavioural disorders in children with idiopathic intracranial hypertension. Journal of Child Neurology, 23, 447–450.
   PubMedGoogle Scholar
• Peng, B. W., Lin, J., Lin, J. Y., Jiang, M. S., & Zhang, T. (2003). Exogenous nitric oxide induces apoptosis in Toxoplasma gondii tachyzoites via a calcium signal transduction pathway. Parasitology, 126, 541–550.
   PubMedGoogle Scholar
• Periard, D., Mayor, C., Aubert, V., & Spertini, F. (2006). Recurrent ibuprofen-induced aseptic meningitis: Evidence against an antigen-specific immune response. Neurology, 67, 539–540.
   PubMedGoogle Scholar
• Pezzella, N., Bouchot, A., Bonhomme, A., Pingret, L., Klein, C., Burlet, H., (1997). Involvement of calcium and calmodulin in Toxoplasma gondii tachyzoite invasion. European Journal of Cell Biology, 74, 92–101.
   PubMed Web of Science ®Google Scholar
• Pfaender, M., D’Souza, W. J., Trost, N., Litewka, L., Paine, M., & Cook, M. (2004). Visual disturbances representing occipital lobe epilepsy in patients with cerebral calcifications and coeliac disease: A case series. Journal of Neurology Neurosurgery and Psychiatry, 75, 1623–1625.
   PubMedGoogle Scholar
• Philippon, J., Poisson, M., & Bleibel, J. M. (1980). Ependymoma of the cauda equina presenting as raised intracranial pressure without ventricle dilatation. One case. Nouvelle Presse Medicale, 9, 303–304.
   PubMedGoogle Scholar
• [PDR] Physicians’ Desk Reference (1998). Montvale, NJ: Medical Economics Co., pp. 417–434.
   Google Scholar
• Płociński, P., Dzidko, K., & Długońska, H. (2007). Prolactin as a modulator of antiparasitic immunity. Wiadomości Parazytologiczne, 53, 263–270.
   PubMedGoogle Scholar
• Prandota, J. (1998). Persisting headache as an early symptom of acquired toxoplasmosis not manifested by enlargement of peripheral lymph nodes. Further cases. Klinika, 5, 930–934.
   Google Scholar
• Prandota, J. (2003). Schönlein-Henoch syndrome. In M. Sieniawska and T. Wyszynska ( ed.), Pediatric Nephrology, vol 2. Warszawa, Poland: PZWL, 213–231.
   Google Scholar
• Prandota, J. (2006). Polemics with the diagnosis of fever in an 11-year-old boy caused by Ebstein-Barr virus infection. Fever and severe headaches could also be the signs of cerebral toxoplasmosis revealed by phenoxymethylpenicillin (Ospen) administration. Pediatria Polska, 81, 388–391.
   Google Scholar
• Prandota, J. (2007). Recurrent headache as the main symptom of acquired cerebral toxoplasmosis in non-human immunodeficiency virus-infected subjects with no lymphadenopathy. The parasite may be responsible for the neurogenic inflammation postulated as a cause of different types of headaches. American Journal of Therapeutics, 14, 63–105.
   PubMedGoogle Scholar
• Prandota, J. (2009a). Idiopathic intracranial hypertension may be caused by reactivation of latent cerebral toxoplasmosis. Effect of various diseases and clinical states. International Journal of Neurosciences, (in press).
   Google Scholar
• Prandota, J. (2009b). Idiopathic intracranial hypertension may be caused by reactivation of latent cerebral toxoplasmosis probably because of disturbances in the host and/or Toxoplasma gondii immune defense mechanisms. Effect of various medications and biologic agents. Recent Patents on CNS Drug Discovery, (in press).
   Google Scholar
• Prandota, J. (2009c). Mollaret meningitis may be caused by reactivation of latent cerebral toxoplasmosis. International Journal of Neuroscience, (in press).
   Google Scholar
• Prandota, J., Sikorska, E., Wołoszczuk, B., & Dzik, E. (1988). Persisting headache as an early symptom of acquired toxoplasmosis not manifested by enlargement of peripheral lymphatic nodes. Pediatria Polska, 63, 483–489.
   PubMedGoogle Scholar
• Provenzale, J. M., & Jinkins, J. R. (1997). Brain and spine imaging findings in AIDS patients. Radiologic Clinics of North America, 35, 1127–1166.
   PubMedGoogle Scholar
• Rangwala, L. M., & Liu, G. T. (2007). Pediatric idiopathic intracranial hypertension. Survey of Ophthalmology, 52, 597–617.
   PubMed Web of Science ®Google Scholar
• Rashmi, K. (2005). Aseptic meningitis: Diagnosis and management. Indian Journal of Pediatrics, 72, 57–63.
   PubMedGoogle Scholar
• Reiter-Owona, I., Seitz, H., Gross, U., Sahm, M., Rockstroh, J. K., & Seitz, H. M. (2000). Is stage conversion the initiating event for reactivation of Toxoplasma gondii in brain tissue of AIDS patients? Journal of Parasitology, 86, 531–536.
   PubMedGoogle Scholar
• River, Y., Averbuch-Heller, L., Weinberger, M., Meiner, M., Mevorach, D., Schlesinger, I., (1994). Antibiotic induced meningitis. Journal of Neurology Neurosurgery and Psychiatry, 57, 705–708.
   PubMed Web of Science ®Google Scholar
• Rocca, M. A., Ceccarelli, A., Falini, A., Colombo, B., Tortorella, P., Bernasconi, L., (2006a). Brain gray matter changes in migraine patients with T2-visible lesions: A 3-T MRI study. Stroke, 37, 1765–1770.
   PubMed Web of Science ®Google Scholar
• Rocca, M. A., Ceccarelli, A., Falini, A., Tortorella, P., Colombo, B., Pagani, E., (2006b). Diffusion tensor magnetic resonance imaging at 3.0 tesla shows subtle cerebral gray matter abnormalities in patients with migraine. Journal of Neurology Neurosurgery and Psychiatry, 77, 686–689.
   PubMedGoogle Scholar
• Roche Herrero, M. C., Arcas Martinez, J., Martinez-Bermejo, A., López Martin, V., Polanco, I., Tendero Gormaz, A., (2001). The prevalence of headache in a population of patients with coeliac disease. Revista de Neurología, 32, 301–309.
   PubMedGoogle Scholar
• Rourke, T., Davies, S., & Samandouras, G. (2008). Serial LPs without serial imaging in idiopathic intracranial hypertension: A lesson learned. Headache, 48, 630–632.
   PubMedGoogle Scholar
• Rozenfeld, C., Martinez, R., Seabra, S., Sant’Anna, C., Goncalves, J. G. R., Bozza, M., (2005). Toxoplasma gondii prevents degeneration by interferon-γ-activated microglia in a mechanism involving inhibition of inducible nitric oxide synthase and transforming growth factor-β1 production by infected microglia. American Journal of Pathology, 167, 1021–1031.
   PubMedGoogle Scholar
• Ryan, P., Hurley, S. F., Johnson, A. M., Salzberg, M., Lee, M. W., North, J. B., (1993). Tumours of the brain and presence of antibodies to Toxoplasma gondii. International Journal of Epidemiology, 22, 412–419.
   PubMedGoogle Scholar
• Sahs, A. L., & Joynt, R. J. (1956). Brain swelling of unknown cause. Neurology, 6, 791–803.
   Web of Science ®Google Scholar
• Saillourglenisson, F., Chene, G., Salmi, L. R., Hafner, R., & Salamon, R. (2000). Effect of dapsone in HIV infected patients: A meta-analysis of finished trials. Revue Epidemiologique de la Santé Publique, 48, 17–30.
   PubMedGoogle Scholar
• Sasayama, D., Shimojima, Y., Gono, T., Kaneko, K., Matsuda, M., & Ikeda, S. (2007). Henoch-Schönlein purpura nephritis complicated by reversible posterior leukoencephalopathy syndrome. Clinical Rheumatology, 26, 1761–1763.
   PubMedGoogle Scholar
• Schlehofer, B., Blettner, M., Preston-Martin, S., Niehoff, D., Wahrendorf, J., Arslan, A., (1999). Role of medical history in brain tumour development. Results from the international adult brain tumour study. International Journal of Cancer, 82, 155–160.
   PubMed Web of Science ®Google Scholar
• Schlehofer, B., Hettinger, I., Ryan, P., Blettner, M., Preston-Martin, S., Little, J., (2005). Occupational risk factors for low grade and high grade glioma: Results from an international case control study of adult brain tumours. International Journal of Cancer, 113, 116–125.
   PubMedGoogle Scholar
• Schwartzbaum, J., Johnsson, F., Ahlbom, A., Preston-Martin, S., Malmer, B., Lönn, S., (2005). Prior hospitalization for epilepsy, diabetes, and stroke and subsequent glioma and meningioma risk. Cancer Epidemiology Biomarkers & Prevention, 14, 643–650.
   PubMed Web of Science ®Google Scholar
• Schwedt, T. J., Guo, Y., & Rothner, A. D. (2006). “Benign” imaging abnormalities in children and adolescents with headache. Headache, 46, 387–398.
   PubMed Web of Science ®Google Scholar
• Seaton, R. A., & France, A. J. (1999). Recurrent aseptic meningitis following non-steroidal anti-inflammatory drugs—A reminder. Postgraduate Medical Journal, 75, 771–772.
   PubMed Web of Science ®Google Scholar
• Seng, S., Makala, L. H., Yokoyama, M., Lim, C., Choi, Y. H., Suzuki, N., (2004). SAG1 is a host-targeted antigen for protection against toxoplasma gondii infection. Pathobiology, 71, 144–151.
   PubMedGoogle Scholar
• Serdaroglu, G., Erhan, E., Tekgul, H., Oksel, F., Erermis, S., Uyar, M., (2002). Sodium valproate prophylaxis in childhood migraine. Headache, 42, 819–822.
   PubMed Web of Science ®Google Scholar
• Shin, J. I., Lee, J. S., & Chung, K. S. (2006). Dapsone therapy for Henoch-Schönlein purpura. Archives of Diseases in Childhood, 91, 714–719.
   Google Scholar
• Shin, J. I., Lee, J. S., Kim, H. D., Lee, J. S., & Lee, Y. M. (2006). Neurologic manifestations and treatment of Henoch-Schönlein purpura. Brain Development, 28, 547.
   PubMedGoogle Scholar
• Silva, N. M., Tafuri, W. L., Alvarez-Leite, J. I., Mineo, J. R., & Gazzinelli, R. T. (2002). Toxoplasma gondii: In vivo expression of BAG-5 and cyst formation is independent of TNF p55 receptor and inducible nitric oxide synthase functions. Microbes and Infection, 4, 261–270.
   PubMedGoogle Scholar
• Skau, M., Brennum, J., Gjerris, F., & Jensen, R. (2005). What is new about idiopathic intracranial hypertension? An updated review of mechanism and treatment. Cephalalgia, 26, 384–399.
   Web of Science ®Google Scholar
• Smith, J. L. (1985). Whence pseudotumor cerebri? Journal of Clinical Neuroophthalmology, 5, 55–56.
   PubMedGoogle Scholar
• Smith, J. R., Franc, D. T., Carter, N. S., Zamora, D., Planck, S. R., & Rosenbaum, J. Y. (2004). Susceptibility of retinal vascular endothelium to infection with Toxoplasma gondii tachyzoites. Investigative Ophthalmology and Visual Science, 45, 1157–1161.
   PubMed Web of Science ®Google Scholar
• Song, H.-O., Ahn, M.-H., Ryu, J.-S., Min, D.-Y., Joo, K.-H., & Lee, Y.-H. (2004). Influence of calcium ion on host cell invasion and intracellular replication by Toxoplasma gondii. Korean Journal of Parasitology, 42, 185–193.
   PubMedGoogle Scholar
• Stahl, W., & Kaneda, Y. (1998). Cerebral anomalies in congenital murine toxoplasmosis: A preliminary report. Tokai Journal of Experimental and Clinical Medicine, 23, 261–265.
   PubMedGoogle Scholar
• Stibbs, H. H. (1985). Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Annals of Tropical Medicine and Parasitology, 79, 153–157.
   PubMed Web of Science ®Google Scholar
• Sun, D. Q., Zhang, Q. Y., Dong, Z. Y., & Bai, F. (2006). Levels of IL-12 produced by dendritic cells and changes of TH1/TH2 balance in children with Henoch-Schönlein purpura. Zhongguo Dang Dai Er Ke Za Zhi, 8, 307–310.
   PubMedGoogle Scholar
• Suzuki, Y. (2002). Immunopathogenesis of cerebral toxoplasmosis. Journal of Infectious Disease, 186(Suppl 2), S234–S240.
   PubMedGoogle Scholar
• Swartz, R. H., & Kern, R. Z. (2004). Migraine is associated with magnetic resonance imaging white matter abnormalities: A meta-analysis. Archives of Neurology, 61, 1366–1368.
   PubMedGoogle Scholar
• Tang, R. B., Chen, S. J., Wu, K. K., Lee, B. H., & Chen, P. Y. (1997). Interferon-gamma in cerebrospinal fluid of children with aseptic meningitis. Zhonghua Yi Xue Za Zhi (Taipei), 59, 248–253.
   PubMedGoogle Scholar
• Toth, C. (2003). Medications and substances as a cause of headache: A systematic review of the literature. Clinical Neuropharmacology, 26, 122–136.
   PubMedGoogle Scholar
• Triki, A., & Couvreur, J. (1971). Neuro-Meningeal manifestations of acquired toxoplasmosis. La Tunisie médicale, 49, 323–329.
   PubMedGoogle Scholar
• Tseng, Y. C., Hsu, H. L., Jung, S. M., & Chen, C. J. (2004). Primary intracranial myxopapillary ependymomas: Report of two cases and review of the literature. Acta Radiologica, 45, 344–347.
   PubMed Web of Science ®Google Scholar
• Tuckova, L., Flegelova, Z., Tlaskalova-Hogenova, H., & Zidek, Z. (2000). Activation of macrophages by food antigens: Enhancing effect of gluten on nitric oxide and cytokine production. Journal of Leukocyte Biology, 67, 312–318.
   PubMedGoogle Scholar
• Vastava, P. B., Pradhan, S., Jha, S., Prasad, K. N., Kumar, S., & Gupta, R. K. (2002). MRI features of toxoplasma encephalitis in the immunocompetent host: A report of two cases. Neuroradiology, 44, 834–838.
   PubMed Web of Science ®Google Scholar
• Vera-Ramirez, M., Charlet, M., & Parry, G. J. (1992). Recurrent aseptic meningitis complicating intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy. Neurology, 42, 1636–1637.
   PubMed Web of Science ®Google Scholar
• Vernooij, M. W., Ikram, M. A., Tanghe, H. L., Vincent, A. J. P. E., Hofman, A., Krestin, G. P., (2007). Incidental findings on brain MRI in the general popualtion. New England Journal of Medicine, 357, 1821–1828.
   PubMed Web of Science ®Google Scholar
• Verrotti, A., Basciani, F., Trotta, D., Greco, R., Morgese, G., & Chiarelli F. (2001). Effect of anticonvulsant drugs on interleukins-1, -2 and -6 and monocyte chemoattractant protein-1. Clinical and Experimental Medicine, 1, 133–136.
   PubMed Web of Science ®Google Scholar
• Vukmirovits, G., Juhasz, P., Janko, M., & Toth, L. (1985). Acute monosymptomatic aseptic meningitis caused by Toxoplasma gondii. Acta Paediatrica Hungarica, 26, 31–34.
   PubMedGoogle Scholar
• Wall, M., Dollar, J. D., Sadun, A. A., & Kardon, R. (1995). Idiopathic intracranial hypertension. Lack of histologic evidence for cerebral edema. Archives of Neurology, 52, 141–145.
   PubMedGoogle Scholar
• Wang, X., Claflin, J., Kang, H., & Suzuki, Y. (2005). Importance of CD8+Vbeta8+ T cells in IFN-gamma-mediated prevention of toxoplasmic encephalitis in genetically resistant BALB/c mice. Journal of Interferon and Cytokine Research, 25,338–344.
   PubMedGoogle Scholar
• Warnick, R. E., Raisanen, J., Adornato, B. T., Prados, M. D., Davis, R. L., Larson, D. A., (1993). Intracranial myxopapillary ependymoma: Case report. Journal of Neurooncology, 15, 251–256.
   PubMedGoogle Scholar
• Weber, F. (1983). The cerebral lesions in congenital toxoplasmosis. Study of 9 personal cases and 61 cases in the literature. Helvetia Paediatrica Acta, (Suppl 48), 1–51.
   Google Scholar
• Webster, J. P., Lamberton, P. H. L., Donelly, C. A., & Torrey, E. F. (2006). Parasites as causative agents of human affective disorders? The impact of anti-psychotic mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour. Proceedings of the Royal Society B, 273, 1023–1030.
   PubMed Web of Science ®Google Scholar
• Weston, P., & Lear, J. (1995). Gliomatosis cerebri or benign intracranial hypertension? Postgraduate Medical Journal, 71, 380–381.
   PubMedGoogle Scholar
• Wills, A. J. (2000). The neurology and neuropathology of coeliac disease. Neuropathology and Applied Neurobiology, 26, 493–496.
   PubMed Web of Science ®Google Scholar
• Woolfenden, A. R., Hukin, J., Poskitt, K. J., & Connolly, M. B. (1998). Encephalopathy complicating henoch-schönlein purpura: Reversible MRI changes. Pediatric Neurology, 19, 74–77.
   PubMedGoogle Scholar
• Yang, Y.-H., Chuang, Y.-H., Wang, L.-C., Huang, H.-Y., Gershwin, M. E., & Chiang, B. L. (2008). The immunobiology of schönlein-henoch purpura. Autoimmunity Reviews, 7, 179–184.
   PubMed Web of Science ®Google Scholar
• Yang, J., Li, C. R., Zu, Y., Wang, G. B., & Li, Y. B. (2006). Role of regulatory T cells in pathogenesis of Henoch-Schönlein purpura in children. Zhonghua Er Ke Za Zhi, 44, 411–414.
   PubMedGoogle Scholar
• Yazar, S., Yaman, O., Eser, B., Altuntas, F., Kurnaz, F., & Sahin, I. (2004). Investigation of anti-Toxoplasma gondii antibodies in patients with neoplasia. Journal of Medical Microbiology, 53, 1183–1186.
   PubMed Web of Science ®Google Scholar
• Young, J. D., & McGwire, B. S. (2005). Infliximab and reactivation of cerebral toxoplasmosis. New England Journal of Medicine, 353, 1530–1531.
   PubMed Web of Science ®Google Scholar
• Yuh, W. T., Nguyen, H. D., Gao, F., Tali, E. T., Fisher, D. J., Mayr, N. A., (1994). Brain parenchymal infection in bone marrow transplantation patients: CT and MR findings. American Journal of Roentgenology, 162, 425–430.
   PubMed Web of Science ®Google Scholar
• Zelnik, N., Pacht, A., Obeid, R., & Lerner, A. (2004). Range of neurologic disorders in patients with celiac disease. Pediatrics, 113, 1672–1676.
   PubMed Web of Science ®Google Scholar
• Zheng, T., Cantor, K. P., Zhang, Y., Keim, S., & Lynch, C. F. (2001). Occupational risk factors for brain cancer: A population-based case-control study in Iowa. Journal of Occupational and Environmental Medicine, 43, 317–324.
   PubMedGoogle Scholar
• Zoch-Zwierz, W., Biernacka, A., Tomaszewska, B., Wasilewska, A., Wierciński, R., Winiecka, W., (2002). Vasculitis of cerebral vessels, probable cause of neurological complications in a child with Schönlein-Henoch purpura. Polski Merkuriusz Lekarski, 12, 306–308.
   PubMedGoogle Scholar